NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

Aethlon Medical, Inc. (AEMD) Stock Analysis

Aethlon Medical, Inc. (AEMD) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

AEMD

$5.07

−$0.24 (−4.52%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare AEMD with… →

AEMD Key Statistics

As of Oct 21, 2026
Trading
Open
$5.31
Previous Close
$5.31
Day's Range
5.07–5.51
52-Week Range
1.41–29.45
Volume
24.76K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.21
Valuation
Market Cap
$8.13M
P/E Ratio
unprofitable
EPS (ttm)Profit attributable to each share over the last twelve months.
−32.97
Financials (FY)
Revenue (FY)
$0.00
Net Income (FY)
−$7.15M
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
1.60M
1-Year Return
−79.80%
Dividend and dates
Earnings Date
November 11, 2026
Avg Volume
2.57M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, AEMD closed at $5.07, −79.80% over 1 year.

Aethlon Medical, Inc. (AEMD) has a market capitalization of $8.13M.

In fiscal 2025, AEMD reported revenue of $0.00.

AEMD Stock Return by Calendar Year

Aethlon Medical, Inc. (AEMD) 10-year return: what $10,000 became

1 year
$10,000 $2,020
−79.80%
5 years
$10,000 $4
−99.96%
10 years
$10,000 $0.18
−99.998%

If you had invested $10,000 in Aethlon Medical, Inc. (AEMD) 10 years ago, at the close on October 21, 2016, it would have been worth $0.18 at the close on October 21, 2026: −99.998% in total, −66.53% a year. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−63.39%
2025−95.97%
2024−60.73%
2023−21.79%
2022−84.95%
2021−24.70%
2020+157.29%
2019−96.14%
2018+46.90%
2017−73.10%
2016 (partial year)−34.88%

As of October 21, 2026.

AEMD Revenue and Earnings by Fiscal Year

FY ends March
Fiscal yearRevenueNet incomeNet margin
2025$0.00−$7.15M—
2024$0.00−$13.39M—
2023$0.00−$12.21M—
2022$574.25K−$12.03M−2,094.9%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$0.00—−$7.29M−$7.15M—
2024$0.00—−$9.34M−$13.39M—
2023$0.00—−$12.64M−$12.21M—
2022$574.25K—−$11.90M−$12.03M−2,094.9%

Annual figures as reported, in the company's reporting currency. As of March 31, 2026.

Recent News

All 13 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Aethlon Medical, Inc. (AEMD) is capitalised at $8.13M on the latest close. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 9.

AEMD last closed at $5.07 on October 21, 2026. That is −$0.24 (−4.52%) against the previous close. Over the past 52 weeks the price has ranged from $1.41 to $29.45. The latest close sits 259.57% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $0.00. The same year closed with a net loss of $7.15M. Trailing earnings per share are −32.97.

Across the 4 fiscal years on file, revenue moves from $574.25K in 2022 to $0.00 in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published.

The trailing one-year total return is −79.80%. Measured over 10 years, that is −66.53% a year compounded. Beta against the wider market is reported at 1.21. Annualized volatility over the trailing 10 years is 213.27%.

Growth & Income

The record shows no dividend for AEMD.

Across the complete calendar years on file, 2020 returned +157.29% and 2019 returned −96.14%. Of the 9 complete calendar years on file, 2 finished higher. So far in 2026 the total return is −63.39%.

Peer Comparison

Aethlon Medical, Inc. (AEMD) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Aethlon Medical, Inc. AEMD $8.13M —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. Aethlon Medical, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Aethlon Medical, Inc.

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.

Visit website →